(ING) ING - Overview
Exchange: NYSE •
Country: Netherlands •
Currency: USD •
Type: Common Stock •
ISIN: US4568371037
Stock: Banking, Loans, Mortgages, Savings, Insurance
Total Rating 48
Risk 57
Buy Signal -0.51
| Risk 5d forecast | |
|---|---|
| Volatility | 30.0% |
| Relative Tail Risk | -4.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.39 |
| Alpha | 37.90 |
| Character TTM | |
|---|---|
| Beta | 0.863 |
| Beta Downside | 0.875 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.86% |
| CAGR/Max DD | 1.77 |
EPS (Earnings per Share)
Revenue
Description: ING ING February 27, 2026
ING Groep N.V. is a diversified European bank headquartered in Amsterdam, operating across five segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, and Wholesale Banking. It offers a full suite of products-including current and savings accounts, time deposits, residential mortgages, SME loans, corporate financing, payments, cash-management, and digital banking-to individual consumers, businesses, and financial institutions.
In its latest quarter (Q4 2025), ING reported a net profit of €1.5 billion and a return on equity of 13%, supported by a CET1 capital ratio of 15.2%. Loan book growth accelerated to 4% year-over-year, while digital active users reached 12 million, reflecting strong adoption of its online platforms. The bank’s performance is being shaped by the European Central Bank’s policy rate, now at 3.5%, which is boosting net interest margins, and by the broader shift toward digital banking across the continent.
For a deeper dive into ING’s valuation and how these trends may affect its outlook, consider exploring additional analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 6.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 3.22 > 1.0 |
| NWC/Revenue: -1716 % < 20% (prev -1427 %; Δ -288.2% < -1%) |
| CFO/TA 0.01 > 3% & CFO 10.49b > Net Income 6.33b |
| Net Debt (116.44b) to EBITDA (9.15b): 12.73 < 3 |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.92b) vs 12m ago -6.84% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 4.00% > 50% (prev 4.40%; Δ -0.40% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
Altman Z''
| A: -0.68 (Total Current Assets 106.31b - Total Current Liabilities 819.08b) / Total Assets 1054.40b |
| B: error (Retained Earnings missing) |
| C: 0.01 (EBIT TTM 9.15b / Avg Total Assets 1037.47b) |
| D: 0.05 (Book Value of Equity 49.70b / Total Liabilities 1003.45b) |
Beneish M
| DSRI: none (Receivables none/984.0m, Revenue 41.55b/44.90b) |
| GMI: 1.01 (GM 96.86% / 97.88%) |
| AQI: 1.01 (AQ_t 0.90 / AQ_t-1 0.88) |
| SGI: 0.93 (Revenue 41.55b / 44.90b) |
| TATA: -0.00 (NI 6.33b - CFO 10.49b) / TA 1054.40b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of ING shares?
As of March 06, 2026, the stock is trading at USD 26.85 with a total of 2,673,543 shares traded.
Over the past week, the price has changed by -9.04%, over one month by -9.17%, over three months by +2.91% and over the past year by +47.31%.
Over the past week, the price has changed by -9.04%, over one month by -9.17%, over three months by +2.91% and over the past year by +47.31%.
Is ING a buy, sell or hold?
ING has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold ING.
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ING price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29 | 7.8% |
| Analysts Target Price | 29 | 7.8% |
ING Fundamental Data Overview March 05, 2026
Market Cap EUR = 66.85b (77.67b USD * 0.8608 USD.EUR)
P/E Trailing = 10.7831
P/E Forward = 9.9206
P/S = 3.1753
P/B = 1.382
P/EG = 1.575
Revenue TTM = 41.55b EUR
EBIT TTM = 9.15b EUR
EBITDA TTM = 9.15b EUR
Long Term Debt = 169.33b EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 169.33b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 116.44b EUR (from netDebt column, last quarter)
Enterprise Value = 129.87b EUR (66.85b + Debt 169.33b - CCE 106.31b)
Interest Coverage Ratio = unknown (Ebit TTM 9.15b / Interest Expense TTM 0.0)
EV/FCF = 12.53x (Enterprise Value 129.87b / FCF TTM 10.37b)
FCF Yield = 7.98% (FCF TTM 10.37b / Enterprise Value 129.87b)
FCF Margin = 24.95% (FCF TTM 10.37b / Revenue TTM 41.55b)
Net Margin = 15.23% (Net Income TTM 6.33b / Revenue TTM 41.55b)
Gross Margin = unknown ((Revenue TTM 41.55b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Tobins Q-Ratio = 0.12 (Enterprise Value 129.87b / Total Assets 1054.40b)
Interest Expense / Debt = 0.03% (Interest Expense 45.0m / Debt 169.33b)
Taxrate = 28.93% (606.0m / 2.10b)
NOPAT = 6.50b (EBIT 9.15b * (1 - 28.93%))
Current Ratio = 0.13 (Total Current Assets 106.31b / Total Current Liabilities 819.08b)
Debt / Equity = 3.41 (Debt 169.33b / totalStockholderEquity, last quarter 49.70b)
Debt / EBITDA = 12.73 (Net Debt 116.44b / EBITDA 9.15b)
Debt / FCF = 11.23 (Net Debt 116.44b / FCF TTM 10.37b)
Total Stockholder Equity = 49.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.61% (Net Income 6.33b / Total Assets 1054.40b)
RoE = 12.66% (Net Income TTM 6.33b / Total Stockholder Equity 49.98b)
RoCE = 4.17% (EBIT 9.15b / Capital Employed (Equity 49.98b + L.T.Debt 169.33b))
RoIC = 2.97% (NOPAT 6.50b / Invested Capital 218.91b)
WACC = 2.59% (E(66.85b)/V(236.19b) * Re(9.10%) + D(169.33b)/V(236.19b) * Rd(0.03%) * (1-Tc(0.29)))
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.61%
[DCF] Terminal Value 80.82% ; FCFF base≈10.37b ; Y1≈6.81b ; Y5≈3.11b
[DCF] Fair Price = N/A (negative equity: EV 98.94b - Net Debt 116.44b = -17.51b; debt exceeds intrinsic value)
EPS Correlation: 54.92 | EPS CAGR: 51.51% | SUE: 2.41 | # QB: 2
Revenue Correlation: 13.25 | Revenue CAGR: 6.37% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.71 | Chg7d=+0.710 | Chg30d=+0.710 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=2.77 | Chg7d=+0.010 | Chg30d=+0.159 | Revisions Net=+2 | Growth EPS=+9.6% | Growth Revenue=+4.3%
EPS next Year (2027-12-31): EPS=3.04 | Chg7d=+0.106 | Chg30d=+0.127 | Revisions Net=+1 | Growth EPS=+9.8% | Growth Revenue=+6.8%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.2% (Discount Rate 9.1% - Earnings Yield 9.3%)
[Growth] Growth Spread = +6.1% (Analyst 5.9% - Implied -0.2%)
P/E Trailing = 10.7831
P/E Forward = 9.9206
P/S = 3.1753
P/B = 1.382
P/EG = 1.575
Revenue TTM = 41.55b EUR
EBIT TTM = 9.15b EUR
EBITDA TTM = 9.15b EUR
Long Term Debt = 169.33b EUR (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 169.33b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 116.44b EUR (from netDebt column, last quarter)
Enterprise Value = 129.87b EUR (66.85b + Debt 169.33b - CCE 106.31b)
Interest Coverage Ratio = unknown (Ebit TTM 9.15b / Interest Expense TTM 0.0)
EV/FCF = 12.53x (Enterprise Value 129.87b / FCF TTM 10.37b)
FCF Yield = 7.98% (FCF TTM 10.37b / Enterprise Value 129.87b)
FCF Margin = 24.95% (FCF TTM 10.37b / Revenue TTM 41.55b)
Net Margin = 15.23% (Net Income TTM 6.33b / Revenue TTM 41.55b)
Gross Margin = unknown ((Revenue TTM 41.55b - Cost of Revenue TTM 1.30b) / Revenue TTM)
Tobins Q-Ratio = 0.12 (Enterprise Value 129.87b / Total Assets 1054.40b)
Interest Expense / Debt = 0.03% (Interest Expense 45.0m / Debt 169.33b)
Taxrate = 28.93% (606.0m / 2.10b)
NOPAT = 6.50b (EBIT 9.15b * (1 - 28.93%))
Current Ratio = 0.13 (Total Current Assets 106.31b / Total Current Liabilities 819.08b)
Debt / Equity = 3.41 (Debt 169.33b / totalStockholderEquity, last quarter 49.70b)
Debt / EBITDA = 12.73 (Net Debt 116.44b / EBITDA 9.15b)
Debt / FCF = 11.23 (Net Debt 116.44b / FCF TTM 10.37b)
Total Stockholder Equity = 49.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.61% (Net Income 6.33b / Total Assets 1054.40b)
RoE = 12.66% (Net Income TTM 6.33b / Total Stockholder Equity 49.98b)
RoCE = 4.17% (EBIT 9.15b / Capital Employed (Equity 49.98b + L.T.Debt 169.33b))
RoIC = 2.97% (NOPAT 6.50b / Invested Capital 218.91b)
WACC = 2.59% (E(66.85b)/V(236.19b) * Re(9.10%) + D(169.33b)/V(236.19b) * Rd(0.03%) * (1-Tc(0.29)))
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.61%
[DCF] Terminal Value 80.82% ; FCFF base≈10.37b ; Y1≈6.81b ; Y5≈3.11b
[DCF] Fair Price = N/A (negative equity: EV 98.94b - Net Debt 116.44b = -17.51b; debt exceeds intrinsic value)
EPS Correlation: 54.92 | EPS CAGR: 51.51% | SUE: 2.41 | # QB: 2
Revenue Correlation: 13.25 | Revenue CAGR: 6.37% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.71 | Chg7d=+0.710 | Chg30d=+0.710 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=2.77 | Chg7d=+0.010 | Chg30d=+0.159 | Revisions Net=+2 | Growth EPS=+9.6% | Growth Revenue=+4.3%
EPS next Year (2027-12-31): EPS=3.04 | Chg7d=+0.106 | Chg30d=+0.127 | Revisions Net=+1 | Growth EPS=+9.8% | Growth Revenue=+6.8%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -0.2% (Discount Rate 9.1% - Earnings Yield 9.3%)
[Growth] Growth Spread = +6.1% (Analyst 5.9% - Implied -0.2%)